RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

Pharmaceutical Industry

A collection of news and information related to Pharmaceutical Industry published by this site and its partners.

Top Pharmaceutical Industry Articles

Displaying items 100-110
  • Baxter reports success in late-stage trial on extended release hemophilia drug

    Baxter reports success in late-stage trial on extended release hemophilia drug
    Baxter International Inc. said Thursday a key hemophilia drug under development met its primary goal in a late-stage clinical study. The drug, known as BAX 855, is essentially a stronger, extended-release version of its flagship hemophilia drug Advate,...
  • Sanofi wins right to market MannKind's inhaled insulin drug Afrezza

    A French pharmaceutical company has agreed to pay up to $925 million for the right to market Afrezza, the recently approved inhaled insulin treatment for diabetes developed by MannKind Corp. of Valencia. Sanofi, based in Paris, said it would pay $150...
  • Experimental Ebola drug 'exhausted,' as experts debate ethical use

    As U.S. medical experts raised concerns Tuesday about the use of experimental drugs to treat the Ebola virus, makers of the unapproved medication ZMapp said their supply has been "exhausted." In a statement published online late Monday, Mapp...
  • FDA approves Belsomra, a new prescription sleep drug

    FDA approves Belsomra, a new prescription sleep drug
    The Food & Drug Administration on Wednesday approved U.S. marketing of the first in a new class of sleep drugs that targets the brain's wakefulness centers to speed the onset of sleep and reduce nighttime awakening. The new medication, which goes by the...
  • SEC reviewing attempted takeover of Botox maker Allergan

    The Securities and Exchange Commission is looking into the way that a Canadian pharmaceutical company and activist investor Bill Ackman have tried to buy Botox maker Allergan Inc. of Irvine. Ackman's hedge fund, Pershing Square Capital Management,...
  • SEC is investigating bid by Valeant and Bill Ackman for Allergan

    The Securities and Exchange Commission is looking into the way a Canadian pharmaceutical company and activist investor Bill Ackman have tried to buy Botox maker Allergan Inc. of Irvine. Word of the investigation came less than a week after Allergan sued...
  • An O.C. couple do the math: Same drug is far cheaper in Canada

    An O.C. couple do the math: Same drug is far cheaper in Canada
    Bent and Henni Christensen consider themselves patriotic Americans and strong supporters of Medicare. Nevertheless, the Huntington Beach couple buy most of their prescription drugs from an online Canadian pharmacy at prices much lower than in the United...
  • Tips for keeping medication costs down

    Tips for keeping medication costs down
    Amanda Greene relies on lidocaine patches to help manage the chronic pain that her Lupus causes. The anesthetic is available as a generic drug, typically sold at a substantially lower price. But this year, the 47-year-old Culver City resident says she's...
  • Sentara invests in pharmacy management company

    Sentara invests in pharmacy management company
    After several months as a customer of NuScriptRX, a 4-year-old pharmacy management company based in Nashville, Tenn., Sentara Healthcare has purchased a 12 percent share in the company. The company has developed a fully automated on-site medication...
  • MannKind agrees to license its inhaled-insulin drug Afrezza to Sanofi

    MannKind agrees to license its inhaled-insulin drug Afrezza to Sanofi
    Less than two months after receiving approval for an inhalable form of insulin, MannKind Corp. agreed to license the drug to Paris-based Sanofi in a deal that could provide the Valencia company with $925 million. Sanofi will initially pay MannKind $150...
  • Close loopholes that let U.S. firms avoid taxes by using inversions

    Close loopholes that let U.S. firms avoid taxes by using inversions
    It's both endearing and infuriating to watch American corporate executives wring their hands about how the injustices of the U.S. tax code are forcing them — forcing them! — to reincorporate overseas through the procedure known as inversion....